![Prognostic utility of intact immunoglobulin Ig′κ/Ig′λ ratios in multiple myeloma patients | Leukemia Prognostic utility of intact immunoglobulin Ig′κ/Ig′λ ratios in multiple myeloma patients | Leukemia](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fleu.2012.159/MediaObjects/41375_2013_Article_BFleu2012159_Fig1_HTML.jpg)
Prognostic utility of intact immunoglobulin Ig′κ/Ig′λ ratios in multiple myeloma patients | Leukemia
![Disease monitoring with quantitative serum IgA levels provides a more reliable response assessment in multiple myeloma patients | Leukemia Disease monitoring with quantitative serum IgA levels provides a more reliable response assessment in multiple myeloma patients | Leukemia](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41375-021-01180-x/MediaObjects/41375_2021_1180_Fig1_HTML.png)
Disease monitoring with quantitative serum IgA levels provides a more reliable response assessment in multiple myeloma patients | Leukemia
![Subsequent anti-myeloma therapy after idecabtagene vicleucel treatment in patients with relapsed/refractory multiple myeloma: A single center analysis. - Abstract - Europe PMC Subsequent anti-myeloma therapy after idecabtagene vicleucel treatment in patients with relapsed/refractory multiple myeloma: A single center analysis. - Abstract - Europe PMC](https://europepmc.org/articles/PMC9019050/bin/41408_2022_662_Tab1_HTML.jpg)
Subsequent anti-myeloma therapy after idecabtagene vicleucel treatment in patients with relapsed/refractory multiple myeloma: A single center analysis. - Abstract - Europe PMC
![Clinical and prognostic significance of t(4;14) translocation in multiple myeloma in the era of novel agents | SpringerLink Clinical and prognostic significance of t(4;14) translocation in multiple myeloma in the era of novel agents | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12185-020-03005-6/MediaObjects/12185_2020_3005_Fig1_HTML.png)
Clinical and prognostic significance of t(4;14) translocation in multiple myeloma in the era of novel agents | SpringerLink
![Characterization and use of the novel human multiple myeloma cell line MC-B11/14 to study biological consequences of CRISPR-mediated loss of immunoglobulin A heavy chain - ScienceDirect Characterization and use of the novel human multiple myeloma cell line MC-B11/14 to study biological consequences of CRISPR-mediated loss of immunoglobulin A heavy chain - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0301472X17308147-exphem3581-fig-0005.jpg)
Characterization and use of the novel human multiple myeloma cell line MC-B11/14 to study biological consequences of CRISPR-mediated loss of immunoglobulin A heavy chain - ScienceDirect
![Precision Medicine for Relapsed Multiple Myeloma on the Basis of an Integrative Multiomics Approach | JCO Precision Oncology Precision Medicine for Relapsed Multiple Myeloma on the Basis of an Integrative Multiomics Approach | JCO Precision Oncology](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/po/2018/po.2018.2/po.18.00019/20190731/images/large/po.18.00019t1.jpeg)
Precision Medicine for Relapsed Multiple Myeloma on the Basis of an Integrative Multiomics Approach | JCO Precision Oncology
![Biomedicines | Free Full-Text | The Cytogenetic Profile of Primary and Secondary Plasma Cell Leukemia: Etiopathogenetic Perspectives, Prognostic Impact and Clinical Relevance to Newly Diagnosed Multiple Myeloma with Differential Circulating Clonal Plasma Biomedicines | Free Full-Text | The Cytogenetic Profile of Primary and Secondary Plasma Cell Leukemia: Etiopathogenetic Perspectives, Prognostic Impact and Clinical Relevance to Newly Diagnosed Multiple Myeloma with Differential Circulating Clonal Plasma](https://www.mdpi.com/biomedicines/biomedicines-10-00209/article_deploy/html/images/biomedicines-10-00209-g001.png)
Biomedicines | Free Full-Text | The Cytogenetic Profile of Primary and Secondary Plasma Cell Leukemia: Etiopathogenetic Perspectives, Prognostic Impact and Clinical Relevance to Newly Diagnosed Multiple Myeloma with Differential Circulating Clonal Plasma
Cytogenetic aberrations in multiple myeloma are associated with shifts in serum immunoglobulin isotypes distribution and levels | Haematologica
![The t(4;14) is associated with poor prognosis in myeloma patients undergoing autologous stem cell transplant - Chang - 2004 - British Journal of Haematology - Wiley Online Library The t(4;14) is associated with poor prognosis in myeloma patients undergoing autologous stem cell transplant - Chang - 2004 - British Journal of Haematology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/95c2f91a-7269-4785-9561-f3cd80995d58/bjh_4867_f2.gif)
The t(4;14) is associated with poor prognosis in myeloma patients undergoing autologous stem cell transplant - Chang - 2004 - British Journal of Haematology - Wiley Online Library
![Light chain myeloma: A brief report from India Singh N, Agrawal N, Sekhri R, Mehta A, Kumar D, Vishwakarma G, Ahmed R, Bhurani D - Indian J Pathol Microbiol Light chain myeloma: A brief report from India Singh N, Agrawal N, Sekhri R, Mehta A, Kumar D, Vishwakarma G, Ahmed R, Bhurani D - Indian J Pathol Microbiol](https://www.ijpmonline.org/articles/2019/62/3/images/IndianJPatholMicrobiol_2019_62_3_441_263479_t3.jpg)
Light chain myeloma: A brief report from India Singh N, Agrawal N, Sekhri R, Mehta A, Kumar D, Vishwakarma G, Ahmed R, Bhurani D - Indian J Pathol Microbiol
![Krüppel-like factor 2 controls IgA plasma cell compartmentalization and IgA responses | Mucosal Immunology Krüppel-like factor 2 controls IgA plasma cell compartmentalization and IgA responses | Mucosal Immunology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41385-022-00503-0/MediaObjects/41385_2022_503_Fig1_HTML.png)
Krüppel-like factor 2 controls IgA plasma cell compartmentalization and IgA responses | Mucosal Immunology
![Single-center Experience in Treating Patients With t(4;14) Multiple Myeloma With and Without Planned Frontline Autologous Stem Cell Transplantation - ScienceDirect Single-center Experience in Treating Patients With t(4;14) Multiple Myeloma With and Without Planned Frontline Autologous Stem Cell Transplantation - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2152265017319432-gr1.jpg)
Single-center Experience in Treating Patients With t(4;14) Multiple Myeloma With and Without Planned Frontline Autologous Stem Cell Transplantation - ScienceDirect
![Co-evolution of tumor and immune cells during progression of multiple myeloma | Nature Communications Co-evolution of tumor and immune cells during progression of multiple myeloma | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-021-22804-x/MediaObjects/41467_2021_22804_Fig1_HTML.png)